With Added Organic Compound Patents (Class 424/638)
-
Patent number: 7887847Abstract: A nutritional supplement composition that promotes visual health and reduces or reverses visual acuity loss by a reduced Vitamin E content from standard supplements with the addition of taurine, omega-3 fatty acids, and non proform Vitamin A carotenoids including lutein and zeaxanthin. The essential ingredients of the nutritional or dietary supplements are Vitamin C, no more than 300 IUs of Vitamin E, Vitamin A at least a portion of which is provided in the form of a proform Vitamin A carotenoid, omega-3 fatty acids, and non proform Vitamin A carotenoids including lutein and/or zeaxanthin. The essential ingredients are provided in a form suitable of oral ingestion or other forms of administration in one or more doses per day.Type: GrantFiled: May 5, 2005Date of Patent: February 15, 2011Inventor: Edward L. Paul, Jr.
-
Publication number: 20100330197Abstract: The present invention provides an oral or enteral composition incorporating not only BCAA but other nutrients to be conducive to comprehensive recovery from fatigue, and improvement in total physical condition. The oral or enteral composition is formulated as a composite of a branched-chain amino acid, coenzyme Q10, L-carnitine, a citric acid, and zinc.Type: ApplicationFiled: February 19, 2009Publication date: December 30, 2010Applicants: EARNEST MEDICINE CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Takashi Higashiguchi, Takako Hatakeyama
-
Publication number: 20100330171Abstract: Nutritional supplements for eye health comprising: an anti-oxidant component; an anti-inflammatory component; and an anti-angiogenic component. The supplements inhibit development and progression of a range of retinal diseases and degenerations, particularly AMD and diabetic eye disease, diabetic retinopathy and diabetic macular edema. The supplements include tocotrienol and green tea extract.Type: ApplicationFiled: January 21, 2010Publication date: December 30, 2010Inventors: Jeffrey P. Gilbard, Johanna M. Seddon
-
Patent number: 7858124Abstract: The present invention relates to an anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use. The composition of the present invention mainly includes the following three ingredients in an adequate ratio: (A) a metal compound having a catalytic function; (B) ionic compound, and (C) an additive. The anti-bacterial, anti-virus, and anti-fungus composition of the present invention is capable of destroying viruses as well as killing bacterial and fungi. Therefore, the composition can be formulated as an aerosol and a film for applying to protection devices such as respirators, masks, gloves, filters, condoms, etc. The present composition can also be used in household, vehicle, hospital, school, restaurant, hotel, internet coffee shop for applying to filter of air-conditioner, tap, stool, interior of elevator and its keyboard.Type: GrantFiled: April 7, 2008Date of Patent: December 28, 2010Assignee: Well-Being Biochemical Corp.Inventors: Jih Ru Hwu, Shwu Chen Tsay
-
Publication number: 20100310673Abstract: An agent for thermally stabilizing lactoferrin, which comprises a nucleic acid as an active ingredient, can be added to lactoferrin to impart thermal stability to lactoferrin. Thermally stabilized lactoferrin can be heat-sterilized at a pH value around a neutral pH value while keeping its activity.Type: ApplicationFiled: March 31, 2009Publication date: December 9, 2010Applicant: MORINAGA MILK INDUSTRY CO., LTD.Inventors: Ayako Horigome, Mai Murata, Koji Yamauchi, Mitsunori Takase, Yasuhiro Takeda, Junichi Hashimoto, Ikumi Kojima
-
Publication number: 20100303784Abstract: The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.Type: ApplicationFiled: August 9, 2010Publication date: December 2, 2010Inventors: Amanda Johanne Kiliaan, Robert Johan Joseph Hageman
-
Patent number: 7838042Abstract: Hypoallergenic metal amino acid chelate compositions, hypoallergenic formulations containing hypoallergenic metal amino acid chelates, methods of preparing hypoallergenic metal amino acid chelate, and methods of administering hypoallergenic metal amino acid chelates are provided. Specifically, the present invention provides metal amino acid chelates that are substantially free of allergens such that administration of the metal amino acid chelates to a subject in an effective amount to cause a medicinal or nutritional result does not produce a discernable adverse allergic reaction. The metal amino acid chelates can include chelates having a naturally occurring amino acid to metal molar ratio of from about 1:1 to 4:1.Type: GrantFiled: April 21, 2004Date of Patent: November 23, 2010Assignee: Albion International, Inc.Inventors: Max R. Motyka, Rick Harnish, Stephen D. Ashmead, H. DeWayne Ashmead
-
Publication number: 20100291174Abstract: The present invention is directed to a biologically active device with a main body made from a polymer, in which bioactive nanoparticles of one or several materials are embedded, wherein the nanoparticles of at least one material proliferatively act on a biological material contacted by the device, and wherein nanoparticles of a different material act in an anti-proliferative manner on biological material in the ambience of the device. The invention is also directed to a method of manufacturing a biologically active device with a main body made from a polymer, wherein nanoparticles of several different materials are dispersed in an injection-moldable fluid, and the fluid is shaped into the polymer main body by means of injection molding and curing, such that the nanoparticles are dispersed in the bulk of the polymer main body.Type: ApplicationFiled: February 1, 2008Publication date: November 18, 2010Inventors: Stephan Barcikowski, Thomas Lenarz, Timo Stoever
-
Publication number: 20100278936Abstract: The present invention provides a composition for topical treatment of skin and mucosal membrane lesions comprising a synergistic combination of copper compound and hypericum perforatum extract.Type: ApplicationFiled: June 20, 2006Publication date: November 4, 2010Applicant: DYNAMICLEAR PTY LTDInventor: John Spurge
-
Publication number: 20100272792Abstract: The use of additives to stabilize DHA when compressed into tablets, or filled as a powder into capsules, for oral administration.Type: ApplicationFiled: April 23, 2010Publication date: October 28, 2010Applicant: Avema Pharma Solution, Division of PL DevelopmentsInventor: Neil Ross
-
Publication number: 20100239553Abstract: Systems and methods are provided herein that provide for promoting cellular health and treatment of cancer, and allied diseases such as diabetes and glaucoma.Type: ApplicationFiled: May 24, 2010Publication date: September 23, 2010Inventors: Arthur W. Bartunek, Robert L. Bard
-
Publication number: 20100233290Abstract: A method for increasing the absorption of magnesium, zinc, and/or copper through the intestines of a subject desiring such an increase, includes administering to the subject a difructose anhydride (DFA) in an amount effective to increase the absorption of magnesium, zinc, and/or copper present in the intestines.Type: ApplicationFiled: May 26, 2010Publication date: September 16, 2010Applicants: FANCL CORPORATION, NIPPON BEET SUGAR MANUFACTURING CO., LTD.Inventors: Takuya SHIOMI, Yasuhide OKUHARA, Akiko TAMURA, Kyoko TOMITA, Norihiro SHIGEMATSU, Hiroto KIKUCHI, Tsutomu ARITSUKA, Fusao TOMITA
-
Patent number: 7790202Abstract: A multi-purpose skin composition which functions as a sunscreen, an anti-perspirant, an insect/pest repellant and/or an antiseptic is disclosed. In some illustrative embodiments, the multi-purpose skin composition includes a powdered repellent formulation having a substantially homogenous powdered mixture including corn starch powder, zinc oxide powder, peppermint powder, basil powder, rosemary powder, eucalyptus powder, copper mica powder and silica powder spheres. In other illustrative embodiments, the multi-purpose skin composition includes a powdered relief formulation having a substantially homogenous powdered mixture comprising corn starch powder, lavender powder, peppermint powder, eucalyptus powder and silica powder spheres.Type: GrantFiled: April 9, 2007Date of Patent: September 7, 2010Inventor: Helen D. Martell
-
Publication number: 20100203160Abstract: Compositions containing the fatty acid docosahexaenoic acid (DHA) in combination with at least one vitamin and mineral are provided to supplement nutrition in a mammalian diet. DHA is present in the composition in concentrated amounts, advantageously in a carrier such as marinol oil, to allow for quantities of DHA sufficient to supply expectant and new mothers and their children as recommended on a daily basis. This DHA may also be used to treat a variety of disorders in children and adults. The compositions advantageously include vitamins, minerals, and optionally other nutrients to provide a nutritional supplement which may be convenient to swallow and taken once a day.Type: ApplicationFiled: April 21, 2010Publication date: August 12, 2010Applicant: XANODYNE PHARMACEUTICALS, INC.Inventors: Roland J. Bydlon, William R. Hurd, Prasad Nidamarty
-
Publication number: 20100196496Abstract: There are provided various compounds and compositions comprising polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds and compositions can be useful as cancer chemopreventive agents. They can also be useful for enhancing solubility of various active agents and enhancing their bioavailability.Type: ApplicationFiled: August 6, 2009Publication date: August 5, 2010Inventor: Samuel FORTIN
-
Patent number: 7758899Abstract: A pharmaceutical composition is provided comprised of a physiologically acceptable source of assimilable copper, a source of salicylic acid or a physiologically acceptable derivative thereof, and vitamin C.Type: GrantFiled: December 3, 2004Date of Patent: July 20, 2010Inventor: John Carter
-
Publication number: 20100178359Abstract: Disclosed is a fungicide for agricultural and horticultural use which is characterized by containing an inorganic copper compound and a polymer thickener having a sulfonyl group. This fungicide for agricultural and horticultural use exhibits higher plant disease-control effects than conventional inorganic copper-based fungicides.Type: ApplicationFiled: December 18, 2006Publication date: July 15, 2010Applicant: RIKENInventors: Yutaka Arimoto, Akiko Hagiwara, Morikatsu Matsunaga, Kenji Ito, Daisuke Kamiya
-
Publication number: 20100178360Abstract: An energetic or nutritive composition includes at least one compound having laxative properties, mineral salts (or electrolytes) such as sodium, potassium, chlorine, calcium, magnesium, phosphor. The composition may also include carbohydrates that may be assimilated by the human digestive system such as glucose, galactose, fructose, maltose, saccharose, polysaccharides.Type: ApplicationFiled: December 8, 2009Publication date: July 15, 2010Applicant: Universite Libre de BruxellesInventors: Jacques Deviere, Nicolas Cauche, Alain Delchambre, Marianna Arvanitaki
-
Patent number: 7754700Abstract: A composition for alleviating symptoms associated with neurotoxicity. The composition may comprise compounds for preventing glutamate mediated neurotoxicity. The composition may include one or more of the following elements: at least one glutamate antagonist, at least one cAMP stimulating agent, at least one antioxidant, vitamin B12, at least one transporter and at least one surfactant. The composition may be used in methods for alleviating tinnitus, Ménière's Disease and/or hearing loss.Type: GrantFiled: April 24, 2006Date of Patent: July 13, 2010Inventor: Seymour F. Trager
-
Publication number: 20100166883Abstract: A composition includes ascorbate, zinc gluconate, and tropocollagen factors including L-proline, glycine and L-lysine. The composition contains the ascorbate, tropocollagen factors and zinc gluconate in concentrations effective to accelerate the production of collagen proteins within at least one collagen-containing tissue of an animal when administered to the animal. The at least one collagen-containing tissue includes at least one of cartilage tissue, tendon tissue, ligament tissue, vitreous humor tissue, connective tissue, hair tissue, bone tissue, and corneal tissue.Type: ApplicationFiled: March 12, 2010Publication date: July 1, 2010Inventor: Kevin Meehan
-
Publication number: 20100158851Abstract: The present invention provides a material for forming an antimicrobial surface coating with multi-level antimicrobial properties, which comprises one or more volatile or gaseous biocides, one or more nonvolatile biocides, and one or more polymers, wherein the volatile or gaseous biocides are encapsulated in the polymers to provide a sustained release of the volatile or gaseous biocides. The present invention further provides a method for preparing the material.Type: ApplicationFiled: December 4, 2009Publication date: June 24, 2010Applicant: The Hong Kong University of Science and Technology Technology Transfer CenterInventors: King Lun Yeung, Wai Kin Leung
-
Publication number: 20100159029Abstract: The present invention provides improved dietary supplements and methods for inhibiting the progression of macular degeneration and promoting healthy vision, while at the same time maintaining general health. The dietary supplements of the invention contain vitamin E and carotenoids in the form of lutein and/or zeaxanthine. The dietary supplements of the invention further contain Vitamin D, Vitamin C, copper and zinc and may also contain such ingredients as rosemary, DHA, and other vitamins and minerals.Type: ApplicationFiled: December 7, 2009Publication date: June 24, 2010Applicant: ALCON RESEARCH, LTD.Inventor: John C. Lang
-
Patent number: 7740692Abstract: A wood preservative composition resulting from admixing components comprising: at least one preservative metal; a quaternary ammonium compound; at least 2 amine compounds; a pH reducing agent, and water, wherein the pH of the composition is from about 7.1 to less than 8.5. Surprisingly, this combination of materials results in a stable solution that can contain a moldicide yet have a commercially acceptable shelf life.Type: GrantFiled: June 7, 2006Date of Patent: June 22, 2010Inventors: Robert W. Grady, William C. Hoffman, Stephen W. King
-
Publication number: 20100151045Abstract: A method is provided for reducing side effects while treating a mammal using indole-3-carbinol, which method includes the steps of administering an effective amount of indole-3-carbinol along with side effect-reducing amounts of a side-effect reducing component. A composition is also provided, as are various combinations of side effect-reducing agents.Type: ApplicationFiled: February 22, 2010Publication date: June 17, 2010Inventor: James H. Zhou
-
Publication number: 20100136104Abstract: In one embodiment of the present invention, a pharmaceutically-acceptable single-dosage formulation consists essentially of about 300 mg of vitamin C; about 1200 IUs of vitamin D3; about 125 IUs of vitamin E; about 25 mg of vitamin B1; about 3.4 mg of vitamin B2; about 35 mg of niacin; about 35 mg of vitamin B6; about 1.25 mg of folate; about 70 mcg of vitamin B12; about 5 mg of pantothenic acid; about 300 mcg of biotin; about 50 mg of calcium; about 35 mg of magnesium; about 35 mg of zinc; about 1 mg of copper; about 125 mcg of selenium; about 150 mcg of chromium; about 25 mg of alpha lipoic acid; about 35 mg of co-enzyme Q-10; about 2 mg of lutein; about 500 mcg of lycopene; about 5 mg of pepper extract; and at least one or more excipients.Type: ApplicationFiled: February 2, 2010Publication date: June 3, 2010Inventors: Steven A. Squashic, Kevin M. Hudy, David C. Purdy
-
Publication number: 20100136133Abstract: The invention provides intradialytic parenteral nutrition (IDPN) solutions with low carbohydrate for the treatment of malnutrition in dialysis patients. The IDPN solutions of the invention are particularly advantageous for the treatment of malnutrition in patients who are diabetic or suffer from other glucose management related pathologies or patients who require strict fluid management.Type: ApplicationFiled: July 7, 2009Publication date: June 3, 2010Inventors: Eileen Moore, Stan Lindenfeld, Michelle Ricker
-
Skin care composition for accelerated production of collagen proteins and method of fabricating same
Patent number: 7700083Abstract: A liquid solution for topical application to the skin of an animal consists of solutes and a solvent, where the solutes include ascorbate, tropocollagen factors, copper, and zinc gluconate. The tropocollagen factors include L-proline, glycine and L-lysine.Type: GrantFiled: August 3, 2006Date of Patent: April 20, 2010Inventor: Kevin Meehan -
Publication number: 20100068299Abstract: The present invention relates to a composition comprising a soluble combination comprising lignosulfonate, a metal salt, and a phosphorus compound selected from the group consisting of phosphorus acid and spontaneously soluble salts thereof, and mixtures thereof. The present invention also relates to the use of such compositions as pesticides.Type: ApplicationFiled: July 1, 2009Publication date: March 18, 2010Inventors: Wilhelmus Maria van der Krieken, Cornelis Johannes Kok, Lucas Henricus Stevens, Evert Davelarr
-
Publication number: 20100068298Abstract: The present invention relates to a nutritional or dietary supplement composition that strengthens and promotes retinal health.Type: ApplicationFiled: December 14, 2007Publication date: March 18, 2010Inventor: Georg L. Kis
-
Publication number: 20100055200Abstract: The present invention discloses a composition that contains (1) an effective amount of an analgesically and/or anti-inflammatory active fraction separated from a mixture of plasma and/or serum, and (2) at least one metal, metal ion or metal salt, in which the mixture has been denatured. Also disclosed are methods of producing the composition for treating a subject afflicted with inflammation and/or pain.Type: ApplicationFiled: March 31, 2009Publication date: March 4, 2010Applicant: CAMBRIDGE SCIENTIFIC PTY LTD, an Australian corporationInventors: Jeffrey D. Edwards, John Palermo
-
Publication number: 20100047363Abstract: A nutritional supplement for patients having chronic kidney disease. The nutritional supplement comprises: Approximate Amount Vitamin C 60-500 Vitamin D (as cholecalciferol) 400-10,000 IU Thiamin (Vitamin B1) 1-50 mg Riboflavin (Vitamin B2) 1.1-10 mg Vitamin B6 2-50 mg Folic Acid 0.4-5 mg wherein the supplement is further characterized in that it does not contain amounts of Vitamin A, Vitamin K, potassium, phosphorus, chromium, or vanadium that would be detrimental to a patient having CKD. In a particular embodiment, the supplement also contains omega fatty acids.Type: ApplicationFiled: January 22, 2009Publication date: February 25, 2010Inventor: John Wigneswaran
-
Publication number: 20100047364Abstract: Individualized responsive dosing dietary supplement systems, compositions, methods of dosing, and processes of producing the same, which allow a consumer to generate individualistic biological responses/effects. More specifically, a dietary supplement system for generating individualized biological conditions/responses which utilizes ultra-low dosage amounts of vitamins, minerals, amino acids, co-enzymes, and/or other nutrients in a bio-active delivery system which preferably avoids first pass metabolism, such that an individual may take multiple doses of the same or different dietary supplement based on varying desired biological response within each 24 hour period is also disclosed.Type: ApplicationFiled: October 27, 2009Publication date: February 25, 2010Inventors: Ricky D. Moneymaker, Larry S. Klesman, Jon S. Theus
-
Patent number: 7662222Abstract: This invention relates to the use of a combination of selected substances in paint to prevent the settlement and growth of different biofouling organisms with a reduced negative effect on the ecosystems compared to present methods.Type: GrantFiled: June 23, 2009Date of Patent: February 16, 2010Assignee: I-Tech ABInventors: Magnus Nydén, Camilla Fant
-
Publication number: 20100028436Abstract: The present invention relates to a polymer matrix, characterized in that it comprises a) an electron donating constituent and b) metal particles comprising at least one metal chosen from palladium, gold, ruthenium, rhodium, osmium, iridium, and platinum. The polymer matrix makes it possible to improve the biocompatibility and antimicrobial properties of substrates coated with said polymer matrix.Type: ApplicationFiled: June 5, 2007Publication date: February 4, 2010Applicant: BACTIGUARD ABInventors: Mattias Ohrlander, Billy Södervall
-
Publication number: 20100015247Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more carrageenans, including lambda carrageenan. Also disclosed are methods for making and using the compositions.Type: ApplicationFiled: September 18, 2009Publication date: January 21, 2010Applicant: The Population Council, Inc.Inventors: Robin A. Maguire, Mitchell Thorn, David M. Phillips
-
Publication number: 20100015245Abstract: The present invention relates to a method of inhibiting biofilms by combinations of antimicrobials, particularly with their synergistic activity against bioFilms. The antimicrobials include combination of copper ion and quaternary ammonium compound or combination of copper ion and peroxide. The invention also include methods for inhibiting biofilm-induced microbial corrosion or fouling.Type: ApplicationFiled: April 23, 2009Publication date: January 21, 2010Inventors: Joe Harrison, Raymond Turner, Howard Ceri
-
Publication number: 20090269419Abstract: The present invention relates to a cosmetic or dermatological composition comprising (i) at least vegetables oils which are rich in omega-3 and/or in omega-6, selected from the group consisting of echium oil, cameline oil, evening primrose oil and borage oil, the vegetable oils being present in a proportion such as to provide an omega-3 to omega-6 ratio within said composition of between 1 and 5, (ii) at least one mineral, preferably in salt form, selected from the group consisting of sodium, calcium and magnesium, preferably magnesium, (iii) at least one trace element selected from the group consisting of zinc, copper and iron, preferably from the group consisting of zinc and copper, (iv) at least vitamin C or derivative thereof, and (v) at least one essential oil, which has anti-free-radical properties, for performing a deep-down treatment which stimulates the microcirculation and the production of energy for the purpose of imparting dynamism to the cells and accelerating their renewal, protecting the collaType: ApplicationFiled: July 2, 2007Publication date: October 29, 2009Inventors: Jean-Louis Pierrisnard, Yves Millou, Katia Fontes, Cecile Tourel
-
Publication number: 20090232748Abstract: This disclosure relates to inventive methods for inactivating viral pathogens comprising providing a virucidal composition comprising a liquid media containing less than 1% weight per volume of a quaternary ammonium compound, such as cetylpyridinium chloride and between 0% and 0.5% weight per volume of citric acid, and contacting a surface targeted for disinfection with the virucidal composition. This disclosure further relates to inventive virucidal compositions comprising a liquid media, a quaternary ammonium compound, such as cetylpyridinium chloride, at a concentration of less than 1% weight per volume, citric acid at a concentration of between 0.0% and 0.5% weight per volume, an extender, and an enhancer.Type: ApplicationFiled: March 18, 2009Publication date: September 17, 2009Applicant: ViraTox, L.L.C.Inventor: Charles L. Capps
-
Publication number: 20090220619Abstract: The present invention relates to nutritional supplements that provide an adult with essential vitamins and minerals that may be lacking in the adult's diet and prevent chronic diseases, such as osteoporosis. A number of combinations of nutrients in set ratios are provided to increase the body's ability to absorb and use the nutrients. These combinations are important in helping the body reach the proper balance required for maximized function. Because adults over the age of 50 years have different nutritional needs, nutritional supplements specifically designed for them are also provided.Type: ApplicationFiled: April 3, 2007Publication date: September 3, 2009Applicant: WyethInventors: Richard Cotter, Randy Stodard
-
Publication number: 20090155381Abstract: A method of treatment and/or prevention of age-related macular degeneration (AMD) wherein, in a first step, the need for treatment or susceptibility to AMD is determined for an individual and, in a second step, a medication comprising lutein and/or zeaxanthin and/or certain antioxidants (or a mixture thereof) is tailored to that individual. The invention also provides a method of determining a substance to be administered to an individual, which individual may be susceptible of having age-related macular degeneration (or an age-related macular degeneration-related disorder) comprising: a) determining the susceptibility of the individual to age-related macular degeneration (usually genetically, by detection of an SNP); and b) on the basis of the determination in a), identifying a substance capable of preventing or treating age-related macular degeneration in that individual.Type: ApplicationFiled: September 8, 2006Publication date: June 18, 2009Inventors: Regina Goralczyc, Antoine De Saizieu, Wolfgang Schalch, Igor Bendik
-
Publication number: 20090148540Abstract: An electrolysis method is described for generating an aqueous solution of copper citrate that has bacteriocidal activity against methicillin resistant Staphylococcus aureus (MRSA) bacteria. Gram positive bacteria are known to be relatively more sensitive to the bacteriocidal activities of copper ions than are Gram negative bacteria. Situations exist in which a disinfectant that is relatively more toxic for Gram positive bacteria will be advantageous over a more broadly active disinfectant, such as that provided by most other disinfectants. In particular, a disinfectant that is relatively selective for Gram positive bacteria could help preserve various non-pathogenic Gram negative microbial populations. The residual Gram negative bacteria can potentially compete with, and thereby lessen the chances of the reintroduction of pathogenic Gram positive bacteria, such as MRSA, Streptococcus, Clostridium difficile and Listeria monocytogenes.Type: ApplicationFiled: December 10, 2007Publication date: June 11, 2009Applicant: MI HOPE INCORPORATEDInventors: William John Martin, Stephen Benet Palmer
-
Publication number: 20090142314Abstract: The use of docosahexaenoic acid in the manufacture of a composition for administration to a pregnant woman for reducing the risk of development of overweight or obesity of the baby in infancy and/or early childhood.Type: ApplicationFiled: May 22, 2007Publication date: June 4, 2009Applicant: NESTEC S.A.Inventors: Ferdinand Haschke, Zdenek Kratky
-
Publication number: 20090068190Abstract: Combinations of a polyunsaturated fatty acid and diindolylmethane and pharmaceutical composition containing such combinations. Further provided are combinations including a polyunsaturated fatty acid, diindolylmethane, and folic acid. Also provided are combinations including diindolylmethane and folic acid. Also provided is a method for increasing the number of normal cells and decreasing the number of aberrant cells in a subject having the steps of administering to the subject a combination comprising a polyunsaturated fatty acid and diindolylmethane.Type: ApplicationFiled: August 27, 2008Publication date: March 12, 2009Applicant: DRUGTECH CORPORATIONInventor: Jonathan David Bortz
-
Patent number: 7497901Abstract: Complexes of copper and/or zinc with molybdate and/or tungstate were solubilized in ammonia or ammoniacal solution providing preservative solutions that fully penetrate wood. With loss of the ammonia from the wood, the complexes were stably retained in the wood providing a long lasting preservative.Type: GrantFiled: December 21, 2006Date of Patent: March 3, 2009Assignee: E. I. dupont de Nemours and CompanyInventors: Albert Gordon Anderson, John Feaster, Damini Patel, Mark Scialdone
-
Publication number: 20090047851Abstract: The present invention is directed to an antimicrobial composition, comprising pyrithione or a pyrithione complex; and a zinc or copper or silver source selected from the group consisting of zinc or copper or silver salts, oxides, hydroxides, sulfates, chlorides, metals, and combinations thereof; wherein the weight ratio of the zinc or copper or silver source to the pyrithione or the pyrithione complex is in the range from about 1:300 to about 50:1, and wherein the antimicrobial composition has an enhanced biocidal effect against a variety of free-living microorganisms or biofilms. Also disclosed is a method of inhibiting the growth of free-living microorganisms or biofilm utilizing the above antimicrobial composition, as well as use of such antimicrobial compositions in various products including fuels, fluids, lubricants, coatings, adhesives, sealants, elastomers, soaps, cosmetics, plastic or woven or non-woven fibers, pharmaceuticals, and as preservatives for the above products.Type: ApplicationFiled: October 21, 2008Publication date: February 19, 2009Inventors: John D. Nelson, Thomas J. Palys, Jon R. Geiger
-
Publication number: 20090047363Abstract: A deodorant antimicrobial fibrous product containing a cancrinite-like mineral containing an antimicrobial metal, a clay mineral, softwood bleached kraft pulp, and hardwood bleached kraft pulp. The weight ratio of the softwood bleached kraft pulp to hardwood bleached kraft pulp is preferably 95/5 to 50/50. The clay mineral is preferably zeolite, sepiolite or bentonite. The deodorant antimicrobial fibrous product is preferably in the form of a sheet or a broken piece thereof, a granule or a three-dimensional molding.Type: ApplicationFiled: February 17, 2006Publication date: February 19, 2009Applicant: Kao CorporationInventors: Takashi Itoi, Ryuichi Nouki
-
Patent number: 7485286Abstract: The present invention provides for wood based panels (e.g., OSB or plywood) that are termite resistant, fungal resistant, or a combination thereof; and methods of manufacturing the same.Type: GrantFiled: October 3, 2006Date of Patent: February 3, 2009Assignee: Potlatch CorporationInventors: Donald J. Hejna, Bruce Trebnick, Ron S. Salisbury, Thomas G. Herion
-
Publication number: 20090016990Abstract: The present invention relates in part to a composition comprising a compound of Formula I or Formula II and at least one other antimicrobial agent. The invention also relates in part to a pharmaceutical composition comprising the composition of claim 1 and a pharmaceutically acceptable carrier or excipient. The invention further relates in part to a method of treating a subject with a microbial illness comprising administering to a subject in need thereof the aforementioned pharmaceutical composition. The invention further relates in part to a method of disinfecting a surface comprising administering to the surface the aforementioned a composition. The invention also relates in part to a coating comprising the aforementioned composition.Type: ApplicationFiled: January 24, 2008Publication date: January 15, 2009Inventors: Randall S. Alberte, Marc W. Mittelman
-
Publication number: 20090017135Abstract: The present invention relates to combinations of 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, and copper or zinc compounds which provide an improved protecting effect against fouling organisms. More particularly, the present invention relates to compositions comprising a combination of 4-bromo-2-(4-chlorophenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, together with one or more copper or zinc compounds selected from Cu2O, Cu(OH)2, CuSO4, copper pyrithione, CuSCN, CuCO3, ZnO, ZnCl2, ZnSO4, zineb, and zinc pyrithione; in respective proportions to provide a synergistic effect against fouling organisms and the use of these compositions for protecting materials against fouling organisms. This invention thus relates to the field of protection of materials, such as underwater objects, protection of wood, wood products, biodegradable materials and coatings.Type: ApplicationFiled: January 31, 2007Publication date: January 15, 2009Inventor: Tony Mathilde Jozef Kempen
-
Publication number: 20090011048Abstract: A dietary supplement for removing or preventing the bio-accumulation of heavy metals in the body includes one or more chelators, precursors therefore, with at least one chelator capable of crossing the blood brain barrier to promote capture of a heavy metal ion from a site in the central nervous system, and a vascular system promoter for assisting in distributing the chelators within the body. The chelator then crosses back through the blood brain barrier with the entrained heavy metal ion. Preferably, one or more secondary chelators promotes binding any of the heavy metal released from the primary chelator and hold it for removal via an excretion pathway. In one embodiment, the supplement includes a cilantro extract to assist the body's' natural defense systems in removing mercury from the human body.Type: ApplicationFiled: September 18, 2008Publication date: January 8, 2009Inventors: Henry D. COLEMAN, R. Neil SUDOL, William J. SAPONE